Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11823)
All Articles published online
|
Publishing Process of This Article
|
Sep 18, 2014 (publication date) through Dec 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Orthopedics
ISSN
2218-5836
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lundquist LM, Cole SW, Sikes ML. Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis. World J Orthop 2014; 5(4): 504-511 [PMID: 25232526 DOI: 10.5312/wjo.v5.i4.504] |
|---|---|
| URL: | https://www.wjgnet.com/2218-5836/full/v5/i4/504.htm |
| Number | Citing Articles |
| 1 |
Hong-Yu Yuan, Xiao-Lan Zhang, Xue-Hui Zhang, Ling Meng, Ji-Fu Wei. Analysis of patents on anti-rheumatoid arthritis therapies issued in China. Expert Opinion on Therapeutic Patents 2015; 25(8): 909 doi: 10.1517/13543776.2015.1044972
|
| 2 |
Hideki Shimaoka, Shinsuke Takeno, Kenji Maki, Takahide Sasaki, Suguru Hasegawa, Yuichi Yamashita. A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancer. Oncology Letters 2017; 14(3): 3019 doi: 10.3892/ol.2017.6473
|
| 3 |
Selvaraj G. Nataraja, Henry N. Yu, Stephen S. Palmer. Discovery and Development of Small Molecule Allosteric Modulators of Glycoprotein Hormone Receptors. Frontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00142
|
| 4 |
Norma Elizabeth Vázquez-Herrera, Antonella Tosti. Current and future pharmacotherapy for alopecia areata. Expert Opinion on Orphan Drugs 2015; 3(4): 419 doi: 10.1517/21678707.2015.1021778
|
| 5 |
Xiao Wu, Xuefang Zeng, Lei Wang, Taijun Hang, Min Song. Identification of related substances in tofacitinib citrate by LC-MS techniques for synthetic process optimization. Journal of Pharmaceutical and Biomedical Analysis 2017; 143: 17 doi: 10.1016/j.jpba.2017.05.012
|
| 6 |
Sherihan Salaheldin Abdelhamid Ibrahim, Kristiina M. Huttunen. Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways. Inflammopharmacology 2021; 29(4): 965 doi: 10.1007/s10787-021-00800-3
|
| 7 |
Sarah Benton, Ronda Farah, Rebecca Freese, Maria Hordinsky. Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review. Dermatologic Therapy 2022; 35(4) doi: 10.1111/dth.15310
|
| 8 |
Hart S. Dengler, Xiumin Wu, Ivan Peng, Cornelia H. Rinderknecht, Youngsu Kwon, Eric Suto, Pawan Bir Kohli, Marya Liimatta, Kathy Barrett, Julia Lloyd, Gary Cain, Mike Briggs, Stephanie Addo, Gary Salmon, Savita Ubhayakar, Gauri Deshmukh, Sheerin K. Shahidi-Latham, Cristine M. Quiason-Huynh, Janet Jackman, John Liu, Nicholas C. Ray, Simon C. Goodacre, Adam Johnson, Brent S. McKenzie, Wyne P. Lee, Mark Zak, Jane R. Kenny, Nico Ghilardi. Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma. Science Translational Medicine 2018; 10(468) doi: 10.1126/scitranslmed.aao2151
|
| 9 |
Shivaprasad Venkatesha, Steven Dudics, Bodhraj Acharya, Kamal Moudgil. Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy. International Journal of Molecular Sciences 2014; 16(1): 887 doi: 10.3390/ijms16010887
|
| 10 |
Christina M. Rollings, Linda V. Sinclair, Hugh J. M. Brady, Doreen A. Cantrell, Sarah H. Ross. Interleukin-2 shapes the cytotoxic T cell proteome and immune environment–sensing programs. Science Signaling 2018; 11(526) doi: 10.1126/scisignal.aap8112
|
| 11 |
Yanmei Li, Yonghua Sun, Shitong Wei, Luyang Zhang, Shihua Zong. Development and evaluation of tofacitinib transdermal system for the treatment of rheumatoid arthritis in rats. Drug Development and Industrial Pharmacy 2021; 47(6): 878 doi: 10.1080/03639045.2021.1916521
|
| 12 |
Bálint Botz, Kata Bölcskei, Zsuzsanna Helyes. Challenges to develop novel anti‐inflammatory and analgesic drugs. WIREs Nanomedicine and Nanobiotechnology 2017; 9(3) doi: 10.1002/wnan.1427
|
| 13 |
Robert Harrington, Shamma Ahmad Al Nokhatha, Richard Conway. <p>JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data</p>. Journal of Inflammation Research 2020; : 519 doi: 10.2147/JIR.S219586
|
| 14 |
Thales R. Hein, Leonardo Peterson, Barbara J. Bartikoski, Juliana Portes, Rafaela C. Espírito Santo, Ricardo M. Xavier. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis. Arthritis Research & Therapy 2022; 24(1) doi: 10.1186/s13075-022-02858-y
|
| 15 |
G C Nicholson, R A Holloway, B R Leaker, I Kilty, M Salganik, L Tan, P J Barnes, L E Donnelly. A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjects. BMJ Open Respiratory Research 2016; 3(1): e000140 doi: 10.1136/bmjresp-2016-000140
|
| 16 |
Licia Maria Henrique da Mota, Bóris Afonso Cruz, Cleandro Pires de Albuquerque, Deborah Pereira Gonçalves, Ieda Maria Magalhães Laurindo, Ivanio Alves Pereira, Jozélio Freire de Carvalho, Geraldo da Rocha Castelar Pinheiro, Manoel Barros Bertolo, Maria Raquel da Costa Pinto, Paulo Louzada‐Junior, Ricardo Machado Xavier, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima. Posicionamento sobre o uso de tofacitinibe no algoritmo do Consenso 2012da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide. Revista Brasileira de Reumatologia 2015; 55(6): 512 doi: 10.1016/j.rbr.2015.08.004
|
| 17 |
Rania T. Malatani, Sana Bilal, Asif Mahmood, Rai Muhammad Sarfraz, Nadiah Zafar, Hira Ijaz, Umaira Rehman, Shehla Akbar, Hala M. Alkhalidi, Heba A. Gad. Development of Tofacitinib Loaded pH-Responsive Chitosan/Mucin Based Hydrogel Microparticles: In-Vitro Characterization and Toxicological Screening. Gels 2023; 9(3): 187 doi: 10.3390/gels9030187
|
| 18 |
Séverine Vermeire, Stefan Schreiber, Robert Petryka, Tanja Kuehbacher, Xavier Hebuterne, Xavier Roblin, Maria Klopocka, Adrian Goldis, Maria Wisniewska-Jarosinska, Andrey Baranovsky, Robert Sike, Kremena Stoyanova, Chantal Tasset, Annegret Van der Aa, Pille Harrison. Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. The Lancet 2017; 389(10066): 266 doi: 10.1016/S0140-6736(16)32537-5
|
| 19 |
Murat Erdağ, Mehmet Balbaba, Nevin İlhan, İlknur Çalık, Fatih Ulaş, Yesari Eröksüz, Hakan Yıldırım. Protective effect of filgotinib in rat endotoxin-induced uveitis model. International Ophthalmology 2021; 41(8): 2905 doi: 10.1007/s10792-021-01851-9
|
| 20 |
Huaxun Wu, Shangxue Yan, Jingyu Chen, Xuexia Luo, Peipei Li, Xiaoyi Jia, Xing Dai, Chun Wang, Qiong Huang, Lihua Liu, Yunfang Zhang, Aiwu Zhou, Yan Chang, LingLing Zhang, Wei Wei. JAK1-STAT3 blockade by JAK inhibitor SHR0302 attenuates inflammatory responses of adjuvant-induced arthritis rats and decreases Th17 and total B cells. Joint Bone Spine 2016; 83(5): 525 doi: 10.1016/j.jbspin.2015.09.002
|
| 21 |
Arezoo Hosseini, Tohid Gharibi, Faroogh Marofi, Mahsa Javadian, Zohreh Babaloo, Behzad Baradaran. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases. Journal of Cellular Physiology 2020; 235(9): 5903 doi: 10.1002/jcp.29593
|
| 22 |
Walter Conca, Ihab Weheba, Mohei-Eldin Abouzied, Abeer Abdelsayed, Yousif Aleyouni, Eid Al‐Mutairy, Nasir Bakshi, Mohammad Khalid. Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.585761
|
| 23 |
Michael E. Weinblatt, Iain B. McInnes, Joel M. Kremer, Pedro Miranda, Jiri Vencovsky, Xiang Guo, Wendy I. White, Patricia C. Ryan, Alex Godwood, Marius Albulescu, David Close, Gerd R. Burmester. A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis. Arthritis & Rheumatology 2018; 70(1): 49 doi: 10.1002/art.40323
|
| 24 |
Feng Huang, Zu-chun Luo. Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials. Clinical Rheumatology 2019; 38(2): 523 doi: 10.1007/s10067-018-4299-4
|
| 25 |
Marta Madej, Patryk Woytala, Marek Frankowski, Łukasz Lubiński, Renata Sokolik, Agata Sebastian, Beata Maciążek-Chyra, Piotr Wiland. Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience. Rheumatology 2019; 57(4): 192 doi: 10.5114/reum.2019.87609
|
| 26 |
Young Ho Lee, Sang-Cheol Bae, Gwan Gyu Song. Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Rheumatology International 2015; 35(12): 1965 doi: 10.1007/s00296-015-3291-4
|
| 27 |
Selvaraj Nataraja, Venkataraman Sriraman, Stephen Palmer. Allosteric Regulation of the Follicle-Stimulating Hormone Receptor. Endocrinology 2018; 159(7): 2704 doi: 10.1210/en.2018-00317
|
| 28 |
Hyo Sun Lee, Soo-Kyung Park, Dong Il Park. Novel treatments for inflammatory bowel disease. The Korean Journal of Internal Medicine 2018; 33(1): 20 doi: 10.3904/kjim.2017.393
|
| 29 |
Patrick P.C. Boor, Petra E. de Ruiter, Patrick S. Asmawidjaja, Erik Lubberts, Luc J.W. van der Laan, Jaap Kwekkeboom. JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa. Translational Research 2017; 188: 67 doi: 10.1016/j.trsl.2016.11.006
|
| 30 |
Thomas Luger, Masayuki Amagai, Brigitte Dreno, Marie-Ange Dagnelie, Wilson Liao, Kenji Kabashima, Tamara Schikowski, Ehrhardt Proksch, Peter M. Elias, Michel Simon, Eric Simpson, Erin Grinich, Matthias Schmuth. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. Journal of Dermatological Science 2021; 102(3): 142 doi: 10.1016/j.jdermsci.2021.04.007
|
| 31 |
Der-Yuan Chen, Ping-Ning Hsu, Chao-Hsiun Tang, Lindsay Claxton, Satish Valluri, Robert A. Gerber. Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan. Journal of Medical Economics 2019; 22(8): 777 doi: 10.1080/13696998.2019.1606813
|
| 32 |
Fatma Budak, Ahmet Cetinkaya, S. Irem Kaya, Esen Bellur Atici, Sibel A. Ozkan. Sensitive determination and electrochemical evaluation of anticancer drug tofacitinib in pharmaceutical and biological samples using glassy carbon and boron-doped diamond electrodes. Diamond and Related Materials 2023; 133: 109751 doi: 10.1016/j.diamond.2023.109751
|
| 33 |
Jeffrey A Lowell, Garvita Sharma, Arun Swaminath, Keith Sultan. Pharmacologic Anticoagulation Is Associated With a Lower Risk of Recurrent Venous Thromboembolic Events During Janus Kinase Inhibitor Use for Patients With a Prior Thrombosis. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae100
|
| 34 |
Mark Löwenberg, Geert D’Haens. Next-Generation Therapeutics for IBD. Current Gastroenterology Reports 2015; 17(6) doi: 10.1007/s11894-015-0444-2
|
| 35 |
Hind M. Almohanna, Marina Perper, Antonella Tosti. Safety concerns when using novel medications to treat alopecia. Expert Opinion on Drug Safety 2018; 17(11): 1115 doi: 10.1080/14740338.2018.1533549
|
| 36 |
Licia Maria Henrique da Mota, Bóris Afonso Cruz, Cleandro Pires de Albuquerque, Deborah Pereira Gonçalves, Ieda Maria Magalhães Laurindo, Ivanio Alves Pereira, Jozélio Freire de Carvalho, Geraldo da Rocha Castelar Pinheiro, Manoel Barros Bertolo, Maria Raquel da Costa Pinto, Paulo Louzada-Junior, Ricardo Machado Xavier, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima. Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib. Revista Brasileira de Reumatologia (English Edition) 2015; 55(6): 512 doi: 10.1016/j.rbre.2015.09.003
|
| 37 |
Hiroaki Hayashi, Ryusuke Kaneko, Shunsuke Demizu, Daichi Akasaka, Manabu Tayama, Takafumi Harada, Hiroki Irie, Yoshio Ogino, Naoko Fujino, Eiji Sasaki. TAS05567, a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor, Abrogates Immunoglobulin-Mediated Autoimmune and Allergic Reactions in Rodent Models. Journal of Pharmacology and Experimental Therapeutics 2018; 366(1): 84 doi: 10.1124/jpet.118.248153
|